Aby J. Mathew, EVP & Chief Scientific Officer at BIOLIFE SOLUTIONS INC (BLFS), sold 60,208 shares at $20.05 ($1.2M) on 2024-11-18, disclosed to the SEC on 2024-11-19.
Scheduled sale ($1.2M) by EVP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.16 | 10,000 | $212K | 17.1% |
| 2 | $21.17 | 15,000 | $318K | 25.7% |
| 3 | $20.05 | 17,604 | $353K | 28.6% |
| 4 | $20.05 | 17,604 | $353K | 28.6% |
| Total | $20.51 avg | 60,208 | $1.2M | 100% |
| Filing → |
| BLFS | SELL | 2025-12-17 | $16K | — | Filing → |
| BLFS | SELL | 2025-11-28 | $14K | — | Filing → |
| BLFS | SELL | 2025-10-14 | $14K | — | Filing → |